📰 Linical Evolution News
Page 24 - Linical Evolution News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Linical Evolution. Real-time updates on events, politics, business and more.
October 1, 2021
The pharma firm reports molnupiravir was shown to cut risk of hospitalization or death by 50% compared to placebos in a positive interim Phase III analysis.
August 17, 2021
An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.
August 12, 2021
The Heart of Athletes study, using Deloitte’s ConvergeHealth MyPath for Clinical platform, aims to examine heart inflammation in athletes with the virus.
June 10, 2021
The two organizations have formed a public-private partnership aimed at improving nonclinical research through better practices and standardization.
June 10, 2021
Dutch biotech, Byondis, today announced positive topline results from a Phase 3 study, which it says confirms the safety and efficacy of its antibody drug conjugate (ADC) - SYD985 - as a treatment for patients with pretreated HER2-positive locally advanced or metastatic breast cancer (MBC).
June 10, 2021
A leader from the virtual research solutions specialist discusses how a greater pushed toward home-based research can lead to a range of benefits.
June 4, 2021
The life-sciences data outfit has chosen former FDA principal deputy commissioner Amy Abernethy to serve as president of its clinical research business.
June 4, 2021
The Digital Health Measurement Collaborative Community is bringing together stakeholders to improve approaches and technologies in research and healthcare.
June 3, 2021
The pharma firm plans to use the StudyTeam platform to accelerate development, ease site burdens and improve patient matching for breast cancer studies. Reify Health has announced pharmaceutical firm AstraZeneca has opted to use the StudyTeam patient enrollment platform to help accelerate clinical development along its breast cancer pipeline. Reify CEO and cofounder Ralph Passarella spoke with Outsourcing-Pharma about the partnership, and how his company’s cloud-ba...
June 3, 2021
The University of Kansas Cancer Center has joined with trial tech provider Complion to develop a shared investigator platform for use in a range of studies.